24/7 MN – (NASDAQ: TTOO) T2 BIOSYSTEMS, INC. shares are climbing this morning and are up 10% on more than 4500 shares.

The stocks cheap at .167 and looks to move north on news. The company announced they received FDA breakthrough designation for their panel

T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel

Molecular Diagnostic Test for Early Detection of Lyme Disease

https://www.globenewswire.com/news-release/2022/07/11/2477217/32489/en/T2-Biosystems-Receives-FDA-Breakthrough-Device-Designation-for-the-T2Lyme-Panel.html/

LEXINGTON, Mass., July 11, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Company’s T2Lyme™ Panel.